# Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection

> **NCT01198236** · PHASE4 · COMPLETED · sponsor: **Zhejiang University** · enrollment: 150 (actual)

## Conditions studied

- Invasive Fungal Infection

## Interventions

- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT01198236
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-11
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2011-10-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01198236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01198236, "Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01198236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*